BioCentury
ARTICLE | Company News

Diagnon Corp. deal

November 14, 1994 8:00 AM UTC

3DIGN and Johns Hopkins University terminated their August agreement to develop cancer treatments and drug delivery technologies because the collaborators were unable to obtain financing through a pri...